Renewal

Syntax Bio

This synthetic biology company develops a CRISPR-based platform to accelerate stem cell differentiation for biopharmaceutical companies developing regenerative medicines and cell therapies.

Cellvoyant

Cellvoyant develops AI-powered imaging platforms and services to predict and optimise stem cell differentiation for biotechnology and pharmaceutical organisations developing cell-based therapies.

Cellino

The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.

Becoming Bio

This company develops robotic metabolic exchange systems and artificial intelligence models to sustain and predict mammalian development outside the body for biotechnology firms.

HexemBio

This company develops stem cell rejuvenation therapies using synthetic environments to treat blood cancer and age-related immune decline in human patients.

Techbio 2.0

This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.

iOrganBio

This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.

ReproGo

This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.